Sustainability

ESG Performance Data

Environment

Management

2019 2020 2021 2022 2023
Group companies with ISO 14001 certification 2 5 3 3 3
Group companies performing environmental audit (internal audit) 3 5 3 3 3
Group companies performing environmental audit (external audit)*1 3 5 3 3 3
Group companies performing environmental audit (audit by H.U. Group)*2 16 7 10 10 10
Employees receiving environmental training*3 5,953 5,783 10,152 9,318 6,720
Violations of environmental laws or regulations 0 0 0 0 0
  • Both internal and external audits performed at SRL and Fujirebio
  • Audit of waste disposal contractors and environmental measurement contractors of Fujirebio
  • Total number of employees receiving group-wide environmental training

Climate change

Unit 2019 2020 2021 2022 2023
CO2 emissions*1 *5
 
 
 
Scope 1 t-CO2 11,162 13,199 14,239 14,020 8,933
Scope 2 t-CO2 22,088 26,295 29,780 34,561 32,486
Scope 3*2 Purchased goods and services t-CO2 121,808 143,017 190,790 189,570 168,419
Capital Goods t-CO2 32,303 64,805 131,413 89,069 60,418
Fuel- and energy-related activities
(not included in scope 1 or scope 2)
t-CO2 5,359 7,128 8,176 7,408 3,711
Transportation and delivery
(upstream)
t-CO2 153,176 203,502 4,682 4,951 4,629
Waste generated in operations t-CO2 4,168 3,408 4,101 3,850 3,948
Business travel t-CO2 1,625 1,706 1,707 1,827 1,601
Employee commuting
(including commuting by car)
t-CO2 3,940 4,562 6,904 8,819 7,323
Upstream leased assets t-CO2 0 0 0
Transportation and delivery
(downstream)
t-CO2 69 70 78
Processing of Sold Products t-CO2 0 0 0
Use of sold products t-CO2 2,001 2,487 16,202 17,229 1,477
End-of-Life Treatment of Sold Products t-CO2 759 834 1,553 1,435 1,158
Leased assets (downstream) t-CO2 6,264 6,997 6,825 7,092 6,727
Franchises t-CO2 0 0 0
Investments t-CO2 1,134 2,667 4,598
Total t-CO2 331,403 438,560 373,555 333,986 264,087
CO2 emissions*5 Scope 1+2 t-CO2 33,250 39,494 44,019 48,581 41,420
CO2 emission intensity*5 Scope 1+2 t-CO2 / ¥100 million
(sales)
19.9 17.4 15.8 18.4 14.4
Energy use (intensity) GJ / ¥100 million
(sales)
402 371 350 402 350
Consumption rate by energy type*4 Renewables
(converted to crude oil or calories)
% 0 0 0 0 0
Fuel % 28 26 24 22 17
Electricity % 72 74 76 78 83
Carbon offset*3
Energy Use*4 Electricity GJ 484,820 620,826 740,279 829,542 803,910
City gas GJ 82,053 85,691 113,127 124,496 117,179
LPG (propane gas) GJ 2,921 12,434 2,102 2,122 2,468
Gasoline GJ 92,596 111,830 112,362 95,990 39,315
Kerosene GJ 7,222 8,432 8,569 6,767 6,408
Heavy oil GJ 2,522 1,781 860 837 636
Light oil GJ 98 191 163 493 377
Renewable energy GJ 0 0 0 0 0
Total GJ 672,231 841,186 977,461 1,062,611 970,292
  • Based on Japan’s Ministry of the Environment’s emission source unit database for calculating green gas emissions through the supply chain
  • Calculation based on GHG Protocol
  • Not disclosed at this time due to difficulty in aggregating data
  • Calculated as a crude oil conversion value
  • Calculated value based on third-party verification from FY2021. (Figures before FY2020 are before third-party verification)

Waste

Units 2019 2020 2021 2022 2023
Waste output per sales*1・2 t / ¥100 million (sales) 2.1 1.5 1.3 1.5 1.7
Amount of waste generated*1 t 3,494 3,452 3,755 4,026 4,676
Breakdown of waste generated*1 General waste t 654 603 415 307 88
Industrial waste t 1,866 1,630 1,749 2,120 3,162
Specially controlled industrial waste t 973 1,220 1,591 1,599 1,426
Waste Plastic Recycling*1 % 71 74 76 86 85
Emissions of PRTR Law Class I Designated Chemical Substances*1・3 t 3.9 0.9 0.6 1.5 1.8
  • Item specialized in Japan
  • Divided by sales amount
  • Total for Fujirebio Inc. only

Water

Units 2019 2020 2021 2022 2023
Water intake*1 Thousand m3 399 392 390 420 413
Water discharge*1 Thousand m3 375 357 378 407 403
Water discharge per sales unit*1・2 Thousand m3 / ¥100 million
(sales)
0.22 0.16 0.14 0.15 0.15
COD (chemical oxygen demand)*1・3 t 0.5 0.4 0.4 0.2 0.5
  • Item specialized in Japan
  • Divided by sales amount
  • Total for Fujirebio Inc. only

Social

Customers

2019 2020 2021 2022 2023
Rate of participation in control survey and quality control reporting at medical institutions using the LUMIPULSE system 88% 93% 89% 87% 87%
Number of voluntarily recall incidents In Vitro Diagnostics business 0 0 1 1 2
Number of serious nonconformities In Vitro Diagnostics business 0 0 0 0 0
Clinical Laboratory Testing business*1 0 1 2 0 0
  • Cases requiring administrative response

Business partners

2019 2020 2021 2022 2023
Number of suppliers performing risk assessment*1 89 33 23 85 54
Percentage of suppliers performing risk assessment*1 100% 54.1% 88.5% 100% 87.1%
Reported cases of child labor at suppliers 0 0 0 0 0
Reported cases of forced labor at suppliers 0 0 0 0 0
  • Primary suppliers of each company and suppliers that account for the top 80% of annual procurement amounts

Employees*1

2019 2020 2021 2022 2023
Number of employees Regular employees (male) 2,261 2,441 2,256 2,156 1,849
Regular employees (female) 1,940 2,306 2,083 1,948 1,633
Managers (male)*2 458 548 572 573 516
Managers (female)*2 74 111 131 146 113
Number of employees by area Japan (male) 2,713 2,734 2,570 2,474 2,365
Japan (female) 2,013 2,114 1,911 1,790 1,746
Asia (male) 5 2 2 0 0
Asia (female) 1 0 0 0 0
North America (male) 1 177 186 181 176
North America (female) 0 200 196 199 200
Europe (male) 0 81 79 79 90
Europe (female) 0 107 111 109 115
Average age 40.0 41.2 41.9 42.1 41.8
Number of employees of new graduates Male 41 60 47 25 46
Female 95 108 39 28 55
Number of new recruits of mid-career employment Male 214 78 147 210 92
Female 125 67 95 132 93
Percentage of female new recruits incl. mid-career employment 46.3% 55.9% 40.9% 40.5% 51.7%
Average years of service   12.0 12.8 11.9 13.2 13.9
Male 13.0 13.5 13.0 13.6 14.7
Female 10.0 11.2 11.3 11.8 12.9
Annual working hours per employee 2,008 1,974 1,971 2,036 1,984
Average days of paid leave taken 12 11 13 18 14
Average rate of paid leave taken 60.1% 54.6% 61.7% 68.1% 69.8%
Work-related deaths 0 0 0 0 0
Lost time injury frequency rate*3 1.68 1.48 3.72 1.43 0.61
Percentage of female managers*2   16.8% 18.6% 20.2% 22.2%
Japan 14.2% 13.4% 12.2% 14.7% 17.8%
Percentage of employees with disabilities*3 1.86% 2.30% 2.24% 2.34% 2.51%
Foreign-national employees 13 25 17 23 22
Percentage of employees taking parental leave (including paternity leave)*3   82.3% 90.2%
Male 71.4% 82.5%
Female 100% 100% 100% 100% 100%
Percentage of employees returning to work after maternity / parental leave 97.0% 97.9% 98.8% 99.1% 94.6%
Employees taking family care leave (short term)*3 3 2 1 2 3
Employees taking family care leave (long term)*3 3 5 2 1 1
Average annual salary of employees(¥)*3 5,713,090 5,902,994 6,366,856 6,737,803 6,565,266
Employee turnover rate*3 6.1% 9.7% 10.5% 8.2% 6.3%
Percentage of employees undergoing medical checkup*3 92.3% 92.4% 87.6% 99.8% 99.0%
Total annual training time for all employees*3 37,864 113,383 158,215 145,092 130,682
Average annual training time per employee*3 8 23 35 32 32
Average monthly overtime hours 21.0 16.9 20.4 16.0 24.6
  • Full-time employees
  • Managers & above
  • Item specialized in Japan

Community

2019 2020 2021 2022 2023
Charitable trust fund(¥)*1 Research subsidies 229,800,000 234,100,000 239,100,000 244,100,000 249,100,000
Koichiro Fujita Award 8,000,000 8,500,000 9,000,000 9,500,000 10,000,000
Nozomu Kosakai Award 15,000,000 15,500,000 16,000,000 16,500,000 17,000,000
  • Cumulative amount for each category

Shareholders

2019 2020 2021 2022 2023
Shareholder / Investor engagement 159 122 104 112 144

Governance

Compliance

2019 2020 2021 2022 2023
Violations of anti-corruption policies and procedures 0 0 0 0 0
Fines for violations stated above (¥) 0 0 0 0 0
Cases reported to H.U. Group Hotline 125 134 116 155 184

Applicable range/period

Applicable range

Environment:

FY2019:Japanese group companies
From FY2020:Japanese and overseas group companies

Social:

FY2019:Japanese group companies
From FY2020:Japanese and overseas group companies

Governance:

Japanese and overseas group companies

(Except where noted)

Period Those figures are calculated based on our fiscal year.
(April 1 to March 31 of the following year)

(Except where noted)